Kwality Pharmaceuticals Ltd approves Q2 FY27 results with consolidated revenue of ₹181.2 crore and net profit of ₹29 crore
- Revenue rose 63% year-on-year and 11.7% sequentially; EBITDA margin increased to 27.5% from 23.4% a year earlier.
- Net profit grew about 106% year-on-year and 13.3% sequentially; the management discussion separately cites ₹50 crore, inconsistent with the financial statements.
- FY27 revenue guidance raised to ₹720 crore or more.
- Board approved B S R & Co. LLP as replacement auditor, subject to shareholder approval, following Vijay Mehra & Co.’s resignation.
